Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

In this articleNVONOVO.B-DKLLYInjection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023.Victoria Klesty | ReutersThe insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight loss drugmakers, Novo Nordisk and Eli Lilly, have said supply woes likely won't go away anytime soon, as the popularity of those medicines continues to soar. But both companies ar ...